tirzepatide gastroparesis case report vs. Side Effects: What to Know GLP-1 Manufacturers Argue Gastroparesis Lawsuits

Sodium-glucose co-transported type-2 inhibitors: pharmacology and peri-operative considerations, Anaesthesia (2018) Blood pressure targets in perioperative care: Provisional considerations based on a comprehensive literature review, Hypertension (American Heart Association) (2018) Treating low blood pressure during surgery may decrease risk of developing postoperative delirium, American Society of Anesthesiologists (2021) JARDIANCE- empagliflozin tablet, film coated, DailyMed (2025) JARDIANCE (empagliflozin tablets), for oral use, Food and Drug Administration (2023) Preoperative management of cardiovascular medications: A society for perioperative assessment and quality improvement (SPAQI) consensus statement, Mayo Clinic Proceedings (2022) Diabetes medicines before surgery, University of Pittsburgh Medical Center (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

Tirzepatide or placebo was initiated at a dose of 2.5 mg once weekly and was increased in 2.5 mg increments every 4 weeks through the 20week dose escalation period

This preparation includes an assessment of eligibility for existing treatments, so you're among the first to transition to Retatrutide when it is approved

And, studies on sleep and stress have shown that both play a significant role in weight management

CNNs Meg Tirrell and Amanda Sealy contributed to this report

The SURMOUNT-4 trial demonstrated that participants who discontinued tirzepatide after achieving weight loss regained a substantial portion of their lost weight over the subsequent 52 weeks, while those who continued treatment maintained their weight reduction